Tae Sung Sohn - Concepedia

Author

Tae Sung Sohn

Also Known As

Ho-Jung Shin, Jae J. Kim, Jun Ho Lee, Kyoung-Mee Kim, Se Hoon Park, Seung Tae Kim, Sohn, Tae, Su Jin Lee, T S Sohn, T. S. Sohn

171

Publications

9.3K

Citations

H-Index

Concepts

All Affiliations

Samsung Medical Center Sungkyunkwan University Samsung (South Korea)National Cancer Center

About

Tae Sung Sohn is an author at Samsung Medical Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	51	4.8K
2	Health Sciences	5	5	238
3	Biostatistics	3	3	298
4	Public Health	2	2	161
5	Engineering	1	1	37

Tae Sung Sohn

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes Răzvan Cristescu, Jeeyun Lee, Michael Nebozhyn, Nature Medicine Gastrointestinal OncologyMedicineMolecular AnalysisGastric Cancer IdentifiesGastroenterology	2015	2.2K
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial Jeeyun Lee, Do Hoon Lim, Sung Kim, Journal of Clinical Oncology	2011	801
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses Se Hoon Park, Tae Sung Sohn, Jeeyun Lee, Journal of Clinical Oncology	2015	424
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach Sung Kim, Do Hoon Lim, Jeeyun Lee, International Journal of Radiation OncologyBiologyPhysics D2 Nodal DissectionSurgical OncologyGastrointestinal OncologyMedicineGastroenterology	2005	288
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆ S.H. Park, D.H. Lim, Tae Sung Sohn, Annals of Oncology	2020	272
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial Jeeyun Lee, Seung Tae Kim, Kyung Kim, Cancer Discovery	2019	222
Long-Term Outcome of Endoscopic Resection vs. Surgery for Early Gastric Cancer: A Non-inferiority-Matched Cohort Study Jeung Hui Pyo, Hyuk Lee, Byung‐Hoon Min, The American Journal of Gastroenterology	2016	193
Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma J. Lee, Teng Ting Lim, Jieun Uhm, Annals of Oncology Metastatic Gastric AdenocarcinomaMedicinePrognosisPathologyCancer Treatment	2007	177
Predictive Factors for Lymph Node Metastasis in Early Gastric Cancer With Submucosal Invasion Ji Yeong An, Yong Hae Baik, Min Gew Choi, Annals of Surgery	2007	170
Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery Jeeyun Lee, Insuk Sohn, In‐Gu Do, PLoS ONE Surgical OncologyFocused Gene ExpressionGastroenterologyPathologyAdjuvant Chemotherapy	2014	137

Page 1